Search clinical trials for: TriMix-DC and ipilimumab

Total 1131 results

Bart Neyns
Vrije Universiteit Brussel

Completed

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma (TriMix-Ipi)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

Belgium
Bart Neyns

Completed

A Study on the Safety and Immunogenicity of Combined Intradermal and Intravenous Administration of an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Melanoma

Belgium
Rob Gruters
Hospital Clinic of Barcelona; Germans Trias i Pujol Hospital; Universitair Ziekenhuis... and other collaborators

Terminated

iHIVARNA Clinical Trial in HIV Infected Individuals (iHIVARNA-01)

HIV Infections

Netherlands, Spain, Belgium
Judit Pich Martínez

Completed

A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy

HIV-infection

Spain
Shanghai Cell Therapy Group Co.,Ltd

Recruiting

Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery

Solid Tumor

China
Memorial Sloan Kettering Cancer Center

Completed

Assessment of the Functional Significance of Accessory Pudendal Arteries

Prostate Cancer

United States
Radboud University Medical Center

Completed

Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients

Melanoma

Netherlands
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; MultiVir, Inc.

Terminated

Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung Cancer

United States
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Department of Health and Human Services

Suspended

A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults

HIV

United States
Fuda Cancer Hospital, Guangzhou
Jinan University Guangzhou

Completed

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Liver Cancer

China
Rockefeller University
Memorial Sloan Kettering Cancer Center

Completed

Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors

Brain Tumors

United States
Huashan Hospital

Recruiting

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

Glioma

China
Radboud University Medical Center

Active, not recruiting

Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI

Colorectal Cancer

Netherlands
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Neoplasms,Ovarian

China
Pawel Kalinski
National Cancer Institute (NCI)

Completed

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

United States
Affiliated Hospital to Academy of Military Medical...

Recruiting

Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
University of Pennsylvania
National Cancer Institute (NCI); Parker Institute for Cancer Immunotherapy

Terminated

DC Vaccine in Colorectal Cancer

Colorectal Cancer

United States
Zwi Berneman
Kom Op Tegen Kanker; Research Foundation Flanders; Stichting tegen Kanker

Active, not recruiting

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission (WIDEA)

Acute Myeloid Leukemia

Belgium
Zogenix MDS, Inc.
Zogenix, Inc.

Withdrawn

A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)

Thymidine Kinase 2 Deficiency
Sichuan University

Unknown

Personalized DC Vaccine for Lung Cancer (SKLB1608)

Carcinoma, Non-Small-Cell Lung

China
Mackay Memorial Hospital

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
Shenzhen Geno-Immune Medical Institute
The No.2 Clinical Hospital of the Ministry of Health

Recruiting

Engineered Dendritic Cell Vaccines for Multiple Myeloma

Multiple Myeloma or Plasmacytoma

China, Russian Federation
Loyola University

Recruiting

Ovarian Dendritic Cell Vaccine Trial

Ovarian Cancer

United States
Charite University, Berlin, Germany

Terminated

DC Vaccination in CML

Myeloid Leukemia, Chronic

Germany
Region Skane

Completed

Volar Locking Plate vs Fragment Specific Fixation in Wrist Fractures

Distal Radius Fractures

Sweden
National Taiwan University Hospital

Not yet recruiting

Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers

Advanced Liver Cancers
Second Affiliated Hospital, School of Medicine,...

Recruiting

Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma

Relapsed and Refractory B-cell Lymphoma

China
University of Florida

Withdrawn

Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

Metastatic Prostate Cancer
José Mordoh, M.D., Ph.D.

Completed

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Melanoma

Argentina
PrimeVax Immuno-Oncology Inc.

Not yet recruiting

Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma

Metastatic Melanoma
Baylor Research Institute
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

United States
The Second Hospital of Shandong University
Shandong Sunstem Biotechnology Co.,Ltd.

Unknown

Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment

Gastric Cancer

China
Helsinki University Central Hospital
Academy of Finland

Unknown

Restoration of Vision After Stroke (REVIS)

Stroke | Hemianopsia | Infarction; Posterior Cerebral Artery

Finland
Beth Israel Deaconess Medical Center
Genzyme, a Sanofi Company

Completed

A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Shenzhen University General Hospital

Recruiting

Treatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine

Malignant Tumor

China
Shenzhen People's Hospital

Unknown

Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer

Carcinoma, Non-Small Cell Lung | Carcinoma, Small Cell Lung

China
Precision Life Sciences Group

Completed

A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma

Glioblastoma Multiforme

United States
Xiaoyi Huang

Unknown

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Renal Cell Carcinoma | Nasopharyngeal Carcinoma | Colorectal Cancer | Lung Cancer

China
Affiliated Hospital to Academy of Military Medical...

Unknown

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Renal Cell Carcinoma

China
Affiliated Hospital to Academy of Military Medical...

Recruiting

Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome (eDC-MDS)

Myelodysplastic Syndromes | Immunotherapy | Dendritic Cell | Hypomethylating Agents

China
Sichuan University

Recruiting

Personalized DC Vaccine for Postoperative Cancer

Hepatocellular Carcinoma | Gastric Cancer | Non-Small-Cell Lung Cancer | Colon Rectal Cancer

China
Oslo University Hospital

Completed

Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer

Prostate Cancer

Norway
Mendus
Uppsala University

Completed

Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Sweden
Beth Israel Deaconess Medical Center
Genzyme, a Sanofi Company

Completed

The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma

Metastatic Melanoma

United States
Guangxi Medical University

Unknown

Study of DC-CIK to Treat Colorectal Cancer

Colorectal Cancer

China
Guangxi Medical University

Unknown

Study of DC-CIK to Treat NPC

Nasopharyngeal Carcinoma

China
Edward Hirschowitz
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer

Lung Cancer

United States
University of Aarhus
Aarhus University Hospital; Hillerod Hospital, Denmark; Regional Hospital Holstebro and other collaborators

Completed

Shared Decision-Making and Dialysis Choice (SDM-DC)

Chronic Kidney Diseases
Affiliated Hospital to Academy of Military Medical...

Unknown

DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With High-risk Soft Tissue Sarcoma

High-risk Soft Tissue Sarcoma

China
OSF Healthcare System

Terminated

Intravenous Fat Emulsions and Premature Infants

Hyperglycemia | Hypertriglyceridemia

United States

Search clinical trials for: TriMix-DC and ipilimumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations